Cargando…

Periplasmic synthesis and purification of the human prolactin antagonist Δ(1-11)-G129R-hPRL

The human prolactin antagonist Δ(1-11)-G129R-hPRL is a 21.9 kDa recombinant protein with 188 amino acids that downregulates the proliferation of a variety of cells expressing prolactin receptors. Periplasmic expression of recombinant proteins in E. coli has been considered an option for obtaining a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Miriam F., Almeida, Larissa A., Pomin, Stephanie A., Silva, Felipe D., Freire, Renan P., Oliveira, João E., Affonso, Regina, Soares, Carlos R. J., Bartolini, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079533/ https://www.ncbi.nlm.nih.gov/pubmed/33905023 http://dx.doi.org/10.1186/s13568-021-01209-5

Ejemplares similares

Expression and characterization of mouse prolactin (mPRL) in CHO dhfr- cells
por: Suzuki, Miriam Fussae, et al.
Publicado: (2014)

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the Multiethnic Cohort
por: Lee, Sulggi A, et al.
Publicado: (2007)

Expression of glycosylated human prolactin in HEK293 cells and related N-glycan composition analysis
por: Silva, Felipe D., et al.
Publicado: (2019)

Polymorphism of the Prolactin (PRL) Gene and Its Effect on Milk Production Traits in Romanian Cattle Breeds
por: Ilie, Daniela Elena, et al.
Publicado: (2023)

PMON129 Pituitary Adenoma Co-Secreting GH, Prolactin and ACTH
por: Wilson, Sarah, et al.
Publicado: (2022)

Effects of prolactin on movement disorders and APOE, GFAP, and PRL receptor gene expression following intracerebral hemorrhage in rats
por: Yousefvand, Shiba, et al.
Publicado: (2021)

Purification and biosynthesis of a derepressible periplasmic arylsulfatase from Chlamydomonas reinhardtii
Publicado: (1988)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019)

Protein fusion tags for efficient expression and purification of recombinant proteins in the periplasmic space of E. coli
por: Malik, Ajamaluddin
Publicado: (2016)

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2021)

Isolation and purification of recombinant immunoglobulin light chain variable domains from the periplasmic space of Escherichia coli
por: Hand, Kieran, et al.
Publicado: (2018)

Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
por: Nyante, Sarah J, et al.
Publicado: (2011)

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
por: Ooki, Akira, et al.
Publicado: (2011)

Analysis of molecular determinants of PRL-3
por: Pascaru, Mihaela, et al.
Publicado: (2009)

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

OR0304 Novel Dual Antagonists Of The Growth Hormone Receptor And The Prolactin Receptor
por: Basu, Reetobrata, et al.
Publicado: (2023)

Prolactin (PRL), placenta growth factor (PIGF) and nerve growth factor receptor (NGFR) as biomarkers for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma (ESCC)
por: Ai, Xiaohong, et al.
Publicado: (2020)

Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion
por: Fiordalisi, James J., et al.
Publicado: (2013)

Depletion of Tissue-Specific Ion Transporters Causes Differential Expression of PRL Targets in Response to Increased Levels of Endogenous PRL
por: Shu, Tingting, et al.
Publicado: (2018)

MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction
por: Zhang, Haojie, et al.
Publicado: (2020)

Effects of High Affinity Leptin Antagonist on Prolactin Receptor Deficient Male Mouse
por: Carré, Nadège, et al.
Publicado: (2014)

Generation of conditional knockout alleles for PRL-3()
por: Yan, Hong, et al.
Publicado: (2011)

Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

Cloning, Optimization of Periplasmic Expression and Purification of Recombinant Granulocyte Macrophage-Stimulating Factor in Escherichia coli BL21 (DE3)
por: Taherian, Elham, et al.
Publicado: (2019)

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
por: Loh, Amos Hong Pheng, et al.
Publicado: (2023)

MON-LB054 Activity of Prolactin Receptor Antagonist-Rapamycin Conjugate in Glioblastoma Multiform
por: Alkharusi, Amira, et al.
Publicado: (2019)

Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL
por: Alam, Zohaib, et al.
Publicado: (2015)

Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3
por: Rubio, Teresa, et al.
Publicado: (2016)

PRL-3 promotes telomere deprotection and chromosomal instability
por: Lian, Shenyi, et al.
Publicado: (2017)

Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity
por: Gehring, Kalle, et al.
Publicado: (2020)

Binocularity Principles of PRL Development in Patients With Macular Disease
por: Tarita-Nistor, Luminita, et al.
Publicado: (2022)

Protein quality control in the bacterial periplasm
por: Miot, Marika, et al.
Publicado: (2004)

Progeny production in the periplasm of Thermosipho globiformans
por: Kuwabara, Tomohiko, et al.
Publicado: (2017)

Stress-Responsive Periplasmic Chaperones in Bacteria
por: Kim, Hyunhee, et al.
Publicado: (2021)

Periplasmic biomineralization for semi-artificial photosynthesis
por: Lin, Yiliang, et al.
Publicado: (2023)

Production of Murine Leukemia RL♂1 Rejection Antigen Peptide pRL1a by Proteolysis of Natural Precursor pRL1b
por: Ono, Toshiro, et al.
Publicado: (1996)

An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
por: Yu, Shengze, et al.
Publicado: (2019)

Enhancement of Human Prolactin Synthesis by Sodium Butyrate Addition to Serum-Free CHO Cell Culture
por: Rodrigues Goulart, Herbert, et al.
Publicado: (2010)

The interplay between prolactin and cardiovascular disease
por: Glezer, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qsi32kups2mpboibinrudt0ona